【摘要】：目的:探討超聲聯(lián)合CA125檢測在卵巢上皮性癌早期診斷中的臨床應(yīng)用價值。方法:回顧2010年1月~2014年6月在貴州省人民醫(yī)院住院手術(shù)治療、經(jīng)術(shù)后病理證實為卵巢上皮性癌的病例124例,從超聲檢查、CA125檢測結(jié)果、病理標(biāo)本組織學(xué)分型、臨床分期方面進(jìn)行統(tǒng)計學(xué)處理。結(jié)果:根據(jù)卵巢惡性腫瘤手術(shù)病理分期(FIGO,2014年),卵巢上皮性癌I期46例、II期14例、III期54例、IV期10例,各期血清CA125統(tǒng)計水平明顯升高(35U/ml),陽性率分別為52.17%、64.29%、90.74%、100.00%。其中晚期(III-IV)明顯高于早期(I-II)(p0.05)。血清CA125檢測陽性92例,總陽性率為74.19%。卵巢粘液性腺癌和透明細(xì)胞癌血清CA125水平也升高,但相對不明顯。在早期,血清CA125檢測陽性率相對低,說明單一CA125檢測篩查卵巢上皮性癌具有一定的局限性。通過超聲檢查提示卵巢癌81例,陽性率為65.32%,僅通過超聲診斷卵巢癌的陽性率并不高,結(jié)合超聲檢查及CA125檢測結(jié)果計算,陽性率達(dá)91.94%,說明兩者聯(lián)合可以顯著提高卵巢上皮性癌診斷的陽性率(p0.05)。病例中有7例術(shù)前超聲顯示為囊性或混合型包塊,未見明顯卵巢癌征象,提示為良性腫瘤或炎性病變,但CA125檢測異常(35U/ml),術(shù)后病理證實為漿液性癌3例,粘液性癌4例,分期均為早期。結(jié)論:1、卵巢上皮性癌患者血清CA125水平升高,且隨分期遞增。卵巢粘液性腺癌和透明細(xì)胞癌血清CA125水平也升高,但相對不明顯。2、超聲聯(lián)合血清CA125檢測,可提高卵巢上皮性癌的早期診斷率。
[Abstract]:Objective: to evaluate the clinical value of ultrasound combined with CA125 in the early diagnosis of ovarian epithelial carcinoma. Methods: from January 2010 to June 2014, 124 cases of ovarian epithelial carcinoma were treated in Guizhou Provincial people's Hospital from January 2010 to June 2014. The results of ultrasonic examination, CA125 examination and histological classification of pathological specimens were reviewed. The clinical stage was treated statistically. Results: according to FIGO, 2014, 46 cases of ovarian epithelial carcinoma, 14 cases of II, 54 cases of III, 10 cases of IV, the level of serum CA125 was significantly increased (35U/ml). The positive rates were 52.17 and 64.29, respectively. The late stage (III-IV) was significantly higher than the early stage (I-II) (p0. 05). The positive rate of serum CA125 was 74.19 in 92 cases. Serum CA125 levels in mucinous adenocarcinoma and clear cell carcinoma of the ovary were also elevated, but relatively insignificant. In the early stage, the positive rate of serum CA125 was relatively low, which indicated that single CA125 was limited in the screening of ovarian epithelial carcinoma. 81 cases of ovarian cancer were diagnosed by ultrasound, the positive rate was 65.322.The positive rate of ovarian cancer diagnosed by ultrasound only was not high. Combined with the results of ultrasound and CA125, the positive rate was 91.94. The results showed that the combination of the two can significantly improve the positive rate of diagnosis of epithelial ovarian carcinoma (p0.05). Among them, 7 cases were diagnosed as cystic or mixed mass by ultrasonography before operation. No obvious signs of ovarian cancer were found, indicating benign tumor or inflammatory lesion, but abnormal CA125 detection (35U/ml), and 3 cases of serous carcinoma confirmed by postoperative pathology. Mucinous carcinoma was found in 4 cases with early stage. Conclusion: 1. The serum CA125 level in patients with epithelial ovarian carcinoma increased with the stage. The level of serum CA125 in mucinous adenocarcinoma and clear cell carcinoma of ovary was also increased, but it was not obvious. 2Ultrasound combined with serum CA125 could improve the early diagnosis rate of epithelial ovarian carcinoma.
【學(xué)位授予單位】：遵義醫(yī)學(xué)院
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號】：R737.31

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張彥;李亞里;;腫瘤標(biāo)記物用于卵巢癌早期診斷的研究進(jìn)展[J];國際婦產(chǎn)科學(xué)雜志;2012年02期

2 吳曉莉;先世偉;;卵巢癌的磁共振動態(tài)增強(qiáng)診斷[J];中國CT和MRI雜志;2014年09期

3 馬珊;;彩色多普勒超聲診斷卵巢癌的價值[J];昆明醫(yī)學(xué)院學(xué)報;2010年07期

4 付琴;李菁;李昱;;彩色多普勒超聲聯(lián)合血清CA_(125)檢測在卵巢癌診斷及鑒別診斷中的價值[J];實用臨床醫(yī)學(xué);2010年01期

5 陳達(dá)麗;彭麗珊;楊們;;經(jīng)陰道彩色多普勒超聲鑒別卵巢腫瘤的臨床價值[J];武漢大學(xué)學(xué)報(醫(yī)學(xué)版);2014年06期

6 曾永群;陳秋月;李凡彩;;CA-125抗原、腫瘤抑制蛋白質(zhì)p53、Ki-67抗原及抑癌基因p27蛋白作為卵巢癌病理輔助診斷指標(biāo)的評價[J];中國全科醫(yī)學(xué);2010年17期

7 張輝;韓波;;檢測CA125、CA153和CA72-4對卵巢癌診斷及療效觀察的臨床價值[J];臨床和實驗醫(yī)學(xué)雜志;2010年08期

8 林紅,吳薇,羅輝,杜力群;肺癌血清CA125測定的診斷價值[J];中國癌癥雜志;2002年02期

9 孫麗娟;吳青青;陳焰;馬玉慶;姚苓;牛會敏;王莉;;超聲評分術(shù)前評價卵巢腫物良惡性及輔助術(shù)式選擇的研究[J];中華醫(yī)學(xué)超聲雜志(電子版);2010年04期

10 張欣,吳令英,李曉江,李洪君,張蓉,劉麗影;盆腔良性腫物伴血清CA_(125)水平升高的臨床意義[J];中華婦產(chǎn)科雜志;2005年03期

，

本文編號：2350239